Eagle Bay Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Eagle Bay Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,655	Closed	-$215K	–	119
2025 Q1	$215K	Sell	2,655 -325	-11%	-$29K	0.18%	102
2024 Q4	$268K	Hold	2,980	–	–	0.17%	91
2024 Q3	$294K	Hold	2,980	–	–	0.11%	132
2024 Q2	$276K	Hold	2,980	–	–	0.17%	92
2024 Q1	$283K	Buy	2,980 +43	+1%	+$3.99K	0.18%	97
2023 Q4	$262K	Hold	2,937	–	–	0.17%	99
2023 Q3	$214K	Sell	2,937 -398	-12%	-$31.8K	0.1%	139
2023 Q2	$277K	Buy	3,335 +721	+28%	+$60.3K	0.16%	94
2023 Q1	$199K	Sell	2,614 -417	-14%	-$34.6K	0.11%	127
2022 Q4	$252K	Sell	3,031 -510	-14%	-$41.3K	0.14%	108
2022 Q3	$281K	Sell	3,541 -1,210	-25%	-$102K	0.17%	90
2022 Q2	$353K	Buy	4,751 +1,039	+28%	+$78K	0.21%	77
2022 Q1	$334K	Buy	3,712 +2,373	+177%	+$219K	0.27%	72
2021 Q4	$288K	Buy	+1,339	New	+$161K	0.18%	81

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Eagle Bay Advisors's XBI Position: Q2 2025 in Review

Eagle Bay Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 2,655 shares — an estimated $215K sold.

Eagle Bay Advisors first reported a position in XBI in Q4 2021 and held it in 14 quarters. The position peaked at $353K in Q2 2022. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Eagle Bay Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
Eagle Bay Advisors sold 2,655 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $215K.
Eagle Bay Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 14 quarters.
Eagle Bay Advisors's State Street SPDR S&P Biotech ETF position peaked at $353K in Q2 2022.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Eagle Bay Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.